Overview
Eiman Aleem practices practicing medicine in London, United Kingdom.
Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, and Langerhans Cell Histiocytosis.
She is actively involved in clinical research, co-authoring 18 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Eiman Aleem
Is Eiman Aleem a top-rated expert for Acute Myeloid Leukemia (AML)?
MediFind is an objective health platform that identifies experts based on real-world data. Eiman Aleem is classified as an Experienced expert for Acute Myeloid Leukemia (AML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Eiman Aleem participate in research or clinical trials?
Yes. Eiman Aleem has published 18 articles and abstracts on conditions like Acute Myeloid Leukemia (AML). You can view a list of Eiman Aleem's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Aleem isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Langerhans Cell HistiocytosisMs. Aleem isExperienced. Learn about Langerhans Cell Histiocytosis.
- LeukemiaMs. Aleem isExperienced. Learn about Leukemia.